Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia

Mainstay Medical Holdings plc today announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain.

DOWNLOAD THE FULL PRESS RELEASE
Category: 2021